GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FORECAST 2019-2027

GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FORECAST 2019-2027

The global active pharmaceutical ingredients market was valued at $172120 million in 2018 & is estimated to generate net revenue of approximately $292598.06 million by 2027, growing at a CAGR of 6.10%. Active pharmaceutical ingredients (APIs) are chemical composites or a mixture of compounds that are used chiefly to have the desired outcome on biological systems.

GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FORECAST 2019-2027

Global Active Pharmaceutical Ingredients Market by Types (Generic Apis, Innovative Apis) by Manufacturers (Captive Apis, Merchant Apis) by Synthesis (Biotech, Synthetic) by Application (Cardiovascular Disease, Oncology, Cns and Neurological Disorders, Orthopedic Disorders, Endocrinology, Pulmonology, Gastrointestinal Disorders, Nephrology, Ophthalmology, Other Application) by Geography.

Request free sample

The global active pharmaceutical ingredients market was valued at $172120 million in 2018 & is estimated to generate net revenue of approximately $292598.06 million by 2027, growing at a CAGR of 6.10%. Active pharmaceutical ingredients (APIs) are chemical composites or a mixture of compounds that are used chiefly to have the desired outcome on biological systems. The following factors primarily drive the active pharmaceutical ingredients market:

  • Growing geriatric population
  • The growing prevalence of infectious diseases and hospital-acquired infections
  • Increasing incidence of age-related diseases

To know more about this report, request a free sample copy.

The important factors that are increasing the growth of the global active pharmaceutical ingredients market are found to be the growing geriatric population and the increasing incidence of age-related diseases. Aging is considered to be the greatest risk factor for the onset of certain diseases related to the cardiovascular and neural system, which are anticipated to drive the demand of the APIs market. The growing demand for drugs to treat the aging population will boost the market growth during the forecast period.

The applications of active pharmaceutical ingredients and APIs synthesis market are used extensively for various purposes. Active pharmaceutical ingredients market by application comprises of cardiovascular disease, oncology, CNS and neurological disorders, orthopedic disorders, endocrinology, pulmonology, gastrointestinal disorders, nephrology, ophthalmology, and other application.

The increasing prevalence of cancer across the world is the key factor attributing to the growth of this market. Hormonal imbalance is a growing concern in the majority of countries that are driving the market growth. Pulmonology refers to the branch of medical science that deals with disorders of the respiratory tract. Some of the APIs used for the treatment of gastrointestinal disorders include famotidine and others. Active pharmaceutical ingredients market by synthesis comprises of biotech and synthetic. Biotech API is mostly peptides and other forms of enzymes. Monoclonal antibodies arouse a patient’s immune system, hence are favoured as APIs in the medical products.

The high cost of investment and production cost and aggressive competition among API manufacturers are the major factors hindering the active pharmaceutical ingredients market. API manufacture requires sophisticated infrastructure, and thus it is capital intensive. API giants are employing strategies to distinguish themselves, which is further escalating the competition in the market.

The global active pharmaceutical ingredients market segments include types, manufacturers, synthesis and applications.

Types are sub-segmented into:

  • Generic APIs
  • Innovative APIs

Manufacturers are sub-segmented into:

  • Captive APIs
  • Merchant APIs

Synthesis is sub-segmented into:

  • Biotech
    • Monoclonal antibodies
    • Recombinant proteins
    • Vaccines
  • Synthetic

Applications are sub-segmented into:

  • Cardiovascular disease
  • Nephrology
  • CNS and neurological disorders
  • Orthopedic disorders
  • Ophthalmology
  • Endocrinology
  • Oncology
  • Pulmonology
  • Gastrointestinal disorders
  • Other application

This report covers the present market conditions and the growth prospects of the global active pharmaceutical ingredients market for 2019-2027 and considered the revenue generated through the sales of active pharmaceutical ingredients for types, manufacturers, synthesis and applications to calculate the market size by considering 2018 as the base year.

Geographically, the global active pharmaceutical ingredients market has been segmented on the basis of four major regions, which include:

  • North America: The United States & Canada
  • Asia-Pacific: China, India, Japan, Australia, South Korea & Rest of APAC
  • Europe: The United Kingdom, France, Germany, Italy, Spain & Rest of Europe
  • Rest of World: Latin America & Middle East, and Africa

The active pharmaceutical ingredients market in North America is expected to hold the largest share by 2027 due to possibilities of higher demand for generic drugs, especially from the US region. Patent expiries of blockbuster drugs are also expected to contribute to market growth. In addition, the increasing prevalence of cancer and other lifestyle-induced diseases is responsible for tremendous growth in R&D activities for drugs. North America active pharmaceutical ingredients market constitutes approximately 40% share.

On the other hand, the Asia-Pacific market is anticipated to the fastest-growing region for the active pharmaceutical ingredients market. The APIs market in APAC is expected to grow considerably during the forecast period. The growth can be attributed to the presence of many vendors that offer generic APIs. Furthermore, the global pharmaceutical companies are outsourcing the production of APIs to the companies in APAC owing to the lower production costs.

The active pharmaceutical ingredients market is segmented based on types which are sub-divided into generic APIs and innovative APIs and also segmented on the basis of manufacturers which is sub-divided into captive APIs and merchant APIs. Captive APIs market growth can be primarily attributed to the growing demand for APIs for manufacturing drugs that are used for treating cancer, and cardiovascular, metabolic, and neurological, disorders. Branded drugs and generic drugs have the same active ingredients. Generics are 30%-80% cheaper than branded drugs. New entrants in this innovative APIs segment are expected to fuel the growth of this market.

The major market players of the global active pharmaceutical ingredients market are:

  • Teva Pharmaceutical Industries
  • Cipla
  • Aurobindo Pharma
  • Sun Pharmaceutical Industries Limited
  • Dr. Reddy’s Laboratories

The company profiles cover the analysis of important players. TEVA Pharmaceutical Industries Ltd. is headquartered in Israel and was established in 1901. The company’s business interest primarily lies in specialty medicines, OTC products, generic drugs, APIs and branded molecules.

Dr. Reddy’s Laboratories Ltd. is a pharmaceutical company headquartered in India. The important segments of the company operations include generics, specialty drugs, and APIs. The company has over 60 APIs in its portfolio.

Key Findings of the global active pharmaceutical ingredients market:

  • Innovative APIs holds the largest market share in terms of active pharmaceutical ingredients type
  • Merchant APIs are the fastest growing manufacturers
  • Biotech is the fastest growing synthesis segment
  • Oncology is the majorly used application
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • INNOVATIVE APIS HOLDS THE LARGEST MARKET SHARE IN TERMS OF ACTIVE PHARMACEUTICAL INGREDIENTS TYPE
      • MERCHANT APIS ARE THE FASTEST GROWING MANUFACTURERS
      • BIOTECH IS THE FASTEST GROWING SYNTHESIS SEGMENT
      • ONCOLOGY IS THE MAJORLY USED APPLICATION
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • GROWING GERIATRIC POPULATION
      • GROWING PREVALENCE OF INFECTIOUS DISEASES AND HOSPITAL ACQUIRED INFECTIONS
      • INCREASING INCIDENCE OF AGE-RELATED DISEASES
    • MARKET RESTRAINTS
      • HIGH COST OF INVESTMENT AND PRODUCTION COST
      • AGGRESSIVE COMPETITION AMONG API MANUFACTURERS
    • MARKET OPPORTUNITIES
      • GAINING POPULARITY FOR TARGETED THERAPY
      • GROWING PREFERENCE FOR OUTSOURCING APIS
      • IMPLEMENTING MEASURES AGAINST COUNTERFEIT DRUGS
    • MARKET CHALLENGES
      • STRINGENT GOVERNMENT REGULATIONS
      • AVAILABILITY OF COUNTERFEIT PRODUCTS
  1. MARKET BY TYPES
    • GENERIC APIS
    • INNOVATIVE APIS
  2. MARKET BY MANUFACTURERS
    • CAPTIVE APIS
    • MERCHANT APIS
  3. MARKET BY SYNTHESIS
    • BIOTECH
      • MONOCLONAL ANTIBODIES
      • RECOMBINANT PROTEINS
      • VACCINES
    • SYNTHETIC
  4. MARKET BY APPLICATION
    • CARDIOVASCULAR DISEASE
    • ONCOLOGY
    • CNS AND NEUROLOGICAL DISORDERS
    • ORTHOPEDIC DISORDERS
    • ENDOCRINOLOGY
    • PULMONOLOGY
    • GASTROINTESTINAL DISORDERS
    • NEPHROLOGY
    • OPHTHALMOLOGY
    • OTHER APPLICATION
  5. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF COMPETITIVE RIVALRY
    • SALES ANALYSIS
    • PESTEL ANALYSIS
    • SUPPLY CHAIN ANALYSIS
    • OPPORTUNITY MATRIX
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • ABBVIE, INC.
      • ALBEMARLE CORPORATION
      • AUROBINDO PHARMA
      • BAYER AG
      • BOEHRINGER INGELHEIM GMBH
      • BRISTOL-MYERS SQUIBB
      • CIPLA
      • REDDY’S LABORATORIES
      • ELI LILLY AND COMPANY
      • LONZA GROUP AG
      • MERCK & CO., INC.
      • MYLAN N.V.
      • NOVARTIS
      • SUN PHARMACEUTICALS INDUSTRIES, LTD.
      • TEVA PHARMACEUTICAL INDUSTRIES LTD.

LIST OF TABLES

TABLE 1        GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 2        GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 3        GLOBAL GENERIC APIS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 4        GLOBAL INNOVATIVE APIS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 5        GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURERS 2019-2027 ($ MILLION)

TABLE 6        GLOBAL CAPTIVE APIS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 7        GLOBAL MERCHANT APIS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 8        GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY SYNTHESIS 2019-2027 ($ MILLION)

TABLE 9        GLOBAL BIOTECH MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 10      GLOBAL BIOTECH MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 11      GLOBAL MONOCLONAL ANTIBODIES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 12      GLOBAL RECOMBINANT PROTEINS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 13      GLOBAL VACCINES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 14      GLOBAL SYNTHETIC MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 15      GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 16      GLOBAL CARDIOVASCULAR DISEASE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 17      GLOBAL ONCOLOGY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 18      GLOBAL CNS AND NEUROLOGICAL DISORDERS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 19      GLOBAL ORTHOPEDIC DISORDERS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 20      GLOBAL ENDOCRINOLOGY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 21      GLOBAL PULMONOLOGY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 22      GLOBAL GASTROINTESTINAL DISORDERS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 23      GLOBAL NEPHROLOGY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 24      GLOBAL OPHTHALMOLOGY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 25      GLOBAL OTHER APPLICATION MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 26      SALES ANALYSIS OF ALL THE MOLECULES 2014-2017 ($ MILLION)

TABLE 27      GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 28      NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 29      EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 30      ASIA PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 31      REST OF WORLD ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 32      ACTIVE PHARMACEUTICAL INGREDIENTS COMPANY MARKET POSITION ANALYSIS 2017

LIST OF FIGURES

FIGURE 1      GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

FIGURE 2      GLOBAL POPULATION BY AGE GROUP

FIGURE 3      GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE BY TYPES 2018 & 2027 (%)

FIGURE 4      GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GENERIC APIS 2019-2027 ($ MILLION)

FIGURE 5      GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY INNOVATIVE APIS 2019-2027 ($ MILLION)

FIGURE 6      GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE BY MANUFACTURERS 2018 & 2027 (%)

FIGURE 7      GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY CAPTIVE APIS 2019-2027 ($ MILLION)

FIGURE 8      GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MERCHANT APIS 2019-2027 ($ MILLION)

FIGURE 9      GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE BY SYNTHESIS 2017 & 2027 (%)

FIGURE 10   GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BIOTECH 2019-2027 ($ MILLION)

FIGURE 11   GLOBAL BIOTECH MARKET BY MONOCLONAL ANTIBODIES 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL BIOTECH MARKET BY RECOMBINANT PROTEINS 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL BIOTECH MARKET BY VACCINES 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY SYNTHETIC 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE BY APPLICATION 2018 & 2027 (%)

FIGURE 16   GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY CARDIOVASCULAR DISEASE 2019-2027 ($ MILLION)

FIGURE 17   GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY ONCOLOGY 2019-2027 ($ MILLION)

FIGURE 18   GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY CNS AND NEUROLOGICAL DISORDERS 2019-2027 ($ MILLION)

FIGURE 19   GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY ORTHOPEDIC DISORDERS 2019-2027 ($ MILLION)

FIGURE 20   GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY ENDOCRINOLOGY 2019-2027 ($ MILLION)

FIGURE 21   GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY PULMONOLOGY 2019-2027 ($ MILLION)

FIGURE 22   GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GASTROINTESTINAL DISORDERS 2019-2027 ($ MILLION)

FIGURE 23   GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY NEPHROLOGY 2019-2027 ($ MILLION)

FIGURE 24   GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY OPHTHALMOLOGY 2019-2027 ($ MILLION)

FIGURE 25   GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)

FIGURE 26   PORTER’S FIVE FORCE MODEL

FIGURE 27   GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 28   THE UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

FIGURE 29   CANADA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

FIGURE 30   THE UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

FIGURE 31   GERMANY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

FIGURE 32   FRANCE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

FIGURE 33   ITALY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

FIGURE 34   SPAIN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

FIGURE 35   REST OF EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

FIGURE 36   JAPAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

FIGURE 37   CHINA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

FIGURE 38   INDIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

FIGURE 39   AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

FIGURE 40   SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

FIGURE 41   REST OF ASIA PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

FIGURE 42   LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

FIGURE 43   MIDDLE EAST AND AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2019-2027 ($ MILLION)

  1. MARKET BY TYPES
    • GENERIC APIS
    • INNOVATIVE APIS
  2. MARKET BY MANUFACTURERS
    • CAPTIVE APIS
    • MERCHANT APIS
  3. MARKET BY SYNTHESIS
    • BIOTECH
      • MONOCLONAL ANTIBODIES
      • RECOMBINANT PROTEINS
      • VACCINES
    • SYNTHETIC
  4. MARKET BY APPLICATION
    • CARDIOVASCULAR DISEASE
    • ONCOLOGY
    • CNS AND NEUROLOGICAL DISORDERS
    • ORTHOPEDIC DISORDERS
    • ENDOCRINOLOGY
    • PULMONOLOGY
    • GASTROINTESTINAL DISORDERS
    • NEPHROLOGY
    • OPHTHALMOLOGY
    • OTHER APPLICATION
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now